Skip to content
Clinical Trials – home

Chlorhexidine Digluconate Solution: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
3+
Countries

In short

This article discusses the use of Chlorhexidine Digluconate Solution in clinical trials, specifically focusing on its potential role in managing skin-related side effects in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). The trial aims to evaluate whether enhanced dermatologic management, which may include the use of Chlorhexidine Digluconate Solution, can reduce the incidence of certain skin-related adverse events in patients undergoing treatment with amivantamab and lazertinib.

At a glance

Study Type
Phase 2, open-label, randomized trial
Primary Objective
Evaluate if enhanced dermatologic management reduces Grade ≥2 DAEIs compared to standard care
Target Population
Adults with locally advanced or metastatic EGFR-mutated NSCLC
Main Treatments
Amivantamab and lazertinib
Dermatologic Management
Enhanced vs. standard-of-care skin management
Chlorhexidine Digluconate Solution Role
Part of enhanced dermatologic management strategy
Primary Endpoint
Incidence of Grade ≥2 DAEIs in first 12 weeks of treatment
Key Exclusion Criteria
Prior systemic treatment for advanced disease, active leptomeningeal disease, certain cardiovascular conditions

What is Chlorhexidine Digluconate Solution?

Chlorhexidine Digluconate Solution is a type of antiseptic medication used primarily for skin disinfection. It belongs to a class of drugs known as antimicrobial agents, which are substances that kill or slow the growth of microorganisms like bacteria and fungi.

Uses of Chlorhexidine Digluconate Solution

Chlorhexidine Digluconate Solution is commonly used for:

  • Skin disinfection before medical procedures
  • Cleaning wounds
  • Preventing infections in minor cuts and burns
  • As part of oral hygiene routines (in lower concentrations)
  • Managing certain skin conditions

In the context of cancer treatment, it's being studied for its potential role in managing skin-related side effects of certain cancer therapies.

How to Use Chlorhexidine Digluconate Solution

Chlorhexidine Digluconate Solution is typically applied directly to the skin. It's important to follow these general steps:

  1. Clean the area to be treated
  2. Apply the solution gently using a clean cotton swab or as directed by your healthcare provider
  3. Allow the solution to dry completely
  4. Do not rinse off unless instructed to do so

Always follow your healthcare provider's specific instructions, as they may vary depending on your individual situation.

Dosage Information

The dosage of Chlorhexidine Digluconate Solution can vary depending on its specific use and concentration. In the clinical trial information provided, the maximum daily dose was listed as 10 ml, with a maximum treatment period of 12 weeks. However, it's crucial to note that:

  • Your healthcare provider will determine the appropriate dosage for your specific needs
  • Never exceed the recommended dosage without consulting your doctor
  • The concentration of the solution can vary, so always check the product label carefully

Precautions and Side Effects

While Chlorhexidine Digluconate Solution is generally safe when used as directed, there are some precautions to keep in mind:

  • Do not use on deep wounds, animal bites, or serious burns without medical supervision
  • Avoid contact with eyes, ears, and mouth
  • If you experience any allergic reactions (such as rash, itching, or difficulty breathing), stop use immediately and seek medical attention
  • Inform your healthcare provider if you are pregnant, breastfeeding, or have any other medical conditions

Possible side effects may include skin irritation, dryness, or rarely, allergic reactions. Always report any unusual symptoms to your healthcare provider.

Current Research

Chlorhexidine Digluconate Solution is currently being studied in the context of cancer treatment. Specifically, it's part of a clinical trial investigating enhanced dermatologic management for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) who are receiving targeted therapies.

The trial aims to evaluate whether enhanced skin care, which may include the use of Chlorhexidine Digluconate Solution, can reduce the incidence of severe skin-related side effects in these patients. This research could potentially lead to improved quality of life for cancer patients undergoing certain treatments.

It's important to note that while this research is promising, Chlorhexidine Digluconate Solution should only be used as directed by a healthcare professional, especially in the context of cancer treatment.

Questions people often ask

Conditions where Chlorhexidine Digluconate Solution is being studied

Each condition opens its own overview and trial list

Trials with Chlorhexidine Digluconate Solution

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).